Clinical Trial Update: Bempedoic Acid Therapy for Polycystic Kidney Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating bempedoic acid for autosomal dominant polycystic kidney disease; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease

Drugs mentioned

• Nexletol (bempedoic acid)

Snippet

Sponsor: Kenneth Hallows | Conditions: ADPKD (Autosomal Dominant Polycystic Kidney Disease) | Phase 2 | Status: NOT_YET_RECRUITING